4.6 Article

Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Caroline Robert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

J. Larkin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Biochemistry & Molecular Biology

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

Simon A. Forbes et al.

NUCLEIC ACIDS RESEARCH (2015)

Review Oncology

Metastatic Melanoma to the Liver

Sanjiv S. Agarwala et al.

CANCER (2014)

Review Dermatology

Overview of uveal melanoma

Lisa M. Martorano et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)

Article Medicine, General & Internal

Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma A Randomized Clinical Trial

Richard D. Carvajal et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Article Multidisciplinary Sciences

Signatures of mutational processes in human cancer

Ludmil B. Alexandrov et al.

NATURE (2013)

Article Medicine, General & Internal

Nivolumab plus Ipilimumab in Advanced Melanoma

Jedd D. Wolchok et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Oncology

The genetics of uveal melanoma: an emerging framework for targeted therapy

J. William Harbour

PIGMENT CELL & MELANOMA RESEARCH (2012)

Article Medicine, General & Internal

Mutations in GNA11 in Uveal Melanoma.

Catherine D. Van Raamsdonk et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Medicine, General & Internal

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)